Manuel Cuenca‐Estrella

28.1k citations

204 papers · 12.4k indexed · 1 hit paper · h-index 62

Impact in

Infectious Diseases top 0.02%
- Antifungal resistance and susceptibility
Epidemiology top 0.1%
- Fungal Infections and Studies
- Nail Diseases and Treatments
- Pneumocystis jirovecii pneumonia detection and treatment

Papers in

Infectious Diseases 187
- Antifungal resistance and susceptibility 187
- Antimicrobial Resistance in Staphylococcus 10
Small Animals 38
- Infectious Diseases and Mycology 31

Co-authors: Juan L. Rodrı́guez-Tudela Emilia Mellado Ana Alastruey‐Izquierdo Alicia Gómez‐López Cornelia Lass‐Flörl J. L. Rodríguez-Tudela Óscar Zaragoza Maiken Cavling Arendrup
Journals: Antimicrobial Agents and Chemotherapy (47 papers)Journal of Clinical Microbiology (26 papers)Clinical Microbiology and Infection (19 papers)Medical Mycology (16 papers)Journal of Antimicrobial Chemotherapy (16 papers)
Partner nations: Spain United Kingdom United States

In The Last Decade

Manuel Cuenca‐Estrella

203 papers receiving 12.1k citations

Hit Papers

align trajectories log scale

EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST) 2012 · 384 citations

Peers

Countries citing papers authored by Manuel Cuenca‐Estrella

Since Specialization

Citations

This map shows the geographic impact of Manuel Cuenca‐Estrella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Cuenca‐Estrella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Cuenca‐Estrella more than expected).

Fields of papers citing papers by Manuel Cuenca‐Estrella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Cuenca‐Estrella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Cuenca‐Estrella. The network helps show where Manuel Cuenca‐Estrella may publish in the future.

Co-authors

The 25 scholars most cited alongside Manuel Cuenca‐Estrella, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Manuel Cuenca‐Estrella Line = papers co-authored together Manuel Cuenca‐Estrella links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	When to change treatment of acute invasive aspergillosis: an expert viewpoint Journal of Antimicrobial Chemotherapy ·Monica A. Slavin, Yee‐Chun Chen, Catherine Cordonnier, Oliver A. Cornely, Manuel Cuenca‐Estrella, J. Peter Donnelly, Andreas H. Groll, Olivier Lortholary, Francisco M. Marty, Márcio Nucci, John Rex, Bart Rijnders, George R. Thompson, Paul E. Verweij, P. Lewis White, Robert W McEwan, Emma Harvey, Johan Maertens	2021	20
2	EUCAST Reference Testing of Rezafungin Susceptibility and Impact of Choice of Plastic Plates Antimicrobial Agents and Chemotherapy ·Maiken Cavling Arendrup, Karin Meinike Jørgensen, Rasmus Krøger Hare, Manuel Cuenca‐Estrella, Óscar Zaragoza	2019	12
3	Triazole Resistance in Aspergillus Species: An Emerging Problem Drugs ·Rocio Garcia‐Rubio, Manuel Cuenca‐Estrella, Emilia Mellado	2017	115
4	Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance Journal of Infection ·Ingrid Urschler, Mireia Puig‐Asensio, Jesús Guinea, Benito Almirante, Belén Padilla, Manuel Almela, Ana Díaz‐Martín, Jesús Rodríguez‐Baño, Manuel Cuenca‐Estrella, José María Aguado	2015	40
5	The Production of Reactive Oxygen Species Is a Universal Action Mechanism of Amphotericin B against Pathogenic Yeasts and Contributes to the Fungicidal Effect of This Drug Antimicrobial Agents and Chemotherapy ·Ana Cecilia Mesa-Arango, Nuria Trevijano‐Contador, Elvira Román, Ruth Sánchez-Fresneda, Cèlia Casas, Enrique Herrero, Juan Carlos Argüelles, Jesús Plá, Manuel Cuenca‐Estrella, Óscar Zaragoza	2014	173
6	Indicaciones clínicas de la monitorización de azoles de uso sistémico. Hacia la optimización del tratamiento de la infección fúngica Revista española de quimioterapia. Suplemento ·Emilio Cendejas‐Bueno, Manuel Cuenca‐Estrella, Alicia Gómez‐López	2014	4
7	EUCAST Technical Note on Aspergillus and amphotericin B, itraconazole, and posaconazole Clinical Microbiology and Infection ·Maiken Cavling Arendrup, Manuel Cuenca‐Estrella, Cornelia Lass‐Flörl, William Hope	2012	94
8	HPLC/UV or bioassay: two valid methods for posaconazole quantification in human serum samples Clinical Microbiology and Infection ·Emilio Cendejas‐Bueno, Agustina Forastiero, J. L. Rodríguez-Tudela, Manuel Cuenca‐Estrella, Alicia Gómez‐López	2011	39
9	Epidemiología actual y diagnóstico de laboratorio de las micosis endémicas en España Enfermedades Infecciosas y Microbiología Clínica ·María José Buitrago, Manuel Cuenca‐Estrella	2011	26
10	Molecular Detection and Identification of Zygomycetes Species from Paraffin-Embedded Tissues in a Murine Model of Disseminated Zygomycosis: a Collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) Evaluation Journal of Clinical Microbiology ·Éric Dannaoui, Patrick Schwarz, Michal Slaný, Juergen Loeffler, Anne Jorde, Manuel Cuenca‐Estrella, Philippe M. Hauser, Silvia Mitidieri, Michel Huerre, Tomáš Freiberger, Peter Gaustad, Felisa L. Sanico, Jacques Billé, David W. Denning, Stéphane Bretagne, Olivier Lortholary	2010	81
11	Correction: Fungal Cell Gigantism during Mammalian Infection PLoS Pathogens ·Óscar Zaragoza, Rocío García‐Rodas, Joshua D. Nosanchuk, Manuel Cuenca‐Estrella, Juan L. Rodrı́guez-Tudela, Arturo Casadevall	2010	70
12	Antifúngicos en el tratamiento de las infecciones sistémicas: importancia del mecanismo de acción, espectro de actividad y resistencias Revista española de quimioterapia. Suplemento ·Manuel Cuenca‐Estrella	2010	9
13	Aspergillus alliaceusandAspergillus flavusco-infection in an acute myeloid leukemia patient Medical Mycology ·Betil Özhak, Ana Alastruey‐Izquierdo, Rabin Saba, Dilara Öğünç, Gözde Öngüt, Ayşen Timurağaoğlu, G. Arslan, Manuel Cuenca‐Estrella, Juan L. Rodrı́guez-Tudela	2010	24
14	Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatus Antimicrobial Agents and Chemotherapy ·Juan L. Rodrı́guez-Tudela, Laura Alcázar‐Fuoli, Emilia Mellado, Ana Alastruey‐Izquierdo, Araceli Monzón, Manuel Cuenca‐Estrella	2008	175
15	International and Multicenter Comparison of EUCAST and CLSI M27-A2 Broth Microdilution Methods for Testing Susceptibilities of Candida spp. to Fluconazole, Itraconazole, Posaconazole, and Voriconazole Journal of Clinical Microbiology ·Ana Espinel‐Ingroff, Francesco Barchiesi, Manuel Cuenca‐Estrella, Michael A. Pfaller, Michael G. Rinaldi, J. L. Rodríguez-Tudela, Paul E. Verweij	2005	118
16	Combined Activity In Vitro of Caspofungin, Amphotericin B, and Azole Agents against Itraconazole-Resistant Clinical Isolates of Aspergillus fumigatus Antimicrobial Agents and Chemotherapy ·Manuel Cuenca‐Estrella, Alicia Gómez‐López, Guillermo García‐Effrón, Laura Alcázar‐Fuoli, Emilia Mellado, María José Buitrago, Juan L. Rodrı́guez-Tudela	2005	60
17	Risk Factors for Invasive Aspergillosis in Solid-Organ Transplant Recipients: A Case-Control Study Clinical Infectious Diseases ·Joan Gavaldà, Óscar Len, Rafael San Juan, José María Aguado, Jesús Fortün, Carlos Lumbreras, Asunción Moreno, (unknown), Marino Blanes, António Ramos, G Rufı́, Mercè Gurguí, José Miguel Cisneros, Miguel Montejo, Manuel Cuenca‐Estrella, J. L. Rodríguez-Tudela, Albert Pahissa	2005	217
18	Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review Journal of Antimicrobial Chemotherapy ·Alicia Gómez‐López, Emilia Mellado, Juan L. Rodrı́guez-Tudela, Manuel Cuenca‐Estrella	2005	87
19	A Point Mutation in the 14α-Sterol Demethylase Gene cyp51A Contributes to Itraconazole Resistance in Aspergillus fumigatus Antimicrobial Agents and Chemotherapy ·Teresa M. Dı́az-Guerra, Emilia Mellado, Manuel Cuenca‐Estrella, J. L. Rodriguez-Tudela	2003	228
20	Identification of Two Different 14-α Sterol Demethylase-Related Genes ( cyp51A and cyp51B ) in Aspergillus fumigatus and Other Aspergillus species Journal of Clinical Microbiology ·Emilia Mellado, Teresa M. Dı́az-Guerra, Manuel Cuenca‐Estrella, J. L. Rodríguez-Tudela	2001	264

About Manuel Cuenca‐Estrella

Manuel Cuenca‐Estrella is a scholar working on Infectious Diseases, Small Animals, Epidemiology, Cell Biology and Applied Microbiology and Biotechnology, having authored 204 papers that have together received 12.4k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (187 papers), Fungal Infections and Studies (125 papers), Plant Pathogens and Fungal Diseases (54 papers), Infectious Diseases and Mycology (31 papers), Mycotoxins in Agriculture and Food (28 papers), Nail Diseases and Treatments (27 papers), Bacterial Identification and Susceptibility Testing (11 papers) and Antimicrobial Resistance in Staphylococcus (10 papers). The work is most often cited by research in Infectious Diseases (10.2k citations), Epidemiology (8.1k citations), Small Animals (1.4k citations), Applied Microbiology and Biotechnology (355 citations) and Cell Biology (2.4k citations). Manuel Cuenca‐Estrella has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Juan L. Rodrı́guez-Tudela, Emilia Mellado, Ana Alastruey‐Izquierdo, Alicia Gómez‐López, Cornelia Lass‐Flörl, J. L. Rodríguez-Tudela, Óscar Zaragoza, Maiken Cavling Arendrup, Laura Alcázar‐Fuoli and Araceli Monzón. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Clinical Microbiology and Infection, Medical Mycology and Journal of Antimicrobial Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact